Technology transfer enables the structured transfer of assay knowledge and processes from sponsors to the central lab responsible for study execution. When done correctly, it ensures scientific fidelity, operational consistency, and regulatory alignment throughout the clinical trial lifecycle.
At Dr. Dangs Central Lab, technology transfers are undertaken selectively, based on study complexity, method criticality, and sponsor recommendations. Each transfer is executed through coordinated planning, clear communication, and close collaboration between sponsor and laboratory technical teams, supported by defined timelines and study-specific implementation plans.
Successful transfers are facilitated by experienced scientific personnel, robust analytical infrastructure, early access to kits and consumables, and strong quality assurance and regulatory oversight. This integrated approach supports accurate replication of sponsor-developed methods and forms a reliable foundation for downstream validation and study execution.
Dr. Dangs Central Lab has successfully completed more than seven technology transfers to date and continues to support ongoing and upcoming programs as a trusted laboratory partner.
